6/9 Venetoclax plus navitoclax RR ALL including T-cell. CR ~ 50%, myelosuppression was important safety finding. Venetoclax combinations are being explored for management of RR ALL. https://t.co/StrhwLEuXT
2,962 followers
428 followers
RT @smbenlazar: Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Le…
15,896 followers
RT @smbenlazar: Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Le…
42 followers
RT @smbenlazar: Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Le…